Introduction of new generic medicines
Company successfully introduced new generic brand of medicine that treats brain tumours and cancers that have spread elsewhere in the body (metastatic brain tumours), types of cancer that originate from white blood cells (Hodgkin’s lymphoma and non-Hodgkin’s lymphomas) and is also used as a “conditioning” treatment before transplantation of the patients own haematopoietic progenitor cells. Another new generic brand medication that is used to treat rheumatoid arthritis was also placed on the market.
